| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerometer-based measures of active and sedentary behavior in relation to breast cancer risk
|
Dallal, Cher M.
|
|
2012
|
134 |
3 |
p. 1279-1290
|
artikel
|
| 2 |
Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients
|
Kang, Eunyoung
|
|
2012
|
134 |
3 |
p. 1189-1197
|
artikel
|
| 3 |
Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis
|
Chen, Xiaosong
|
|
2012
|
134 |
3 |
p. 957-967
|
artikel
|
| 4 |
Accuracy of quantitative ultrasound elastography for differentiation of malignant and benign breast abnormalities: a meta-analysis
|
Sadigh, Gelareh
|
|
2012
|
134 |
3 |
p. 923-931
|
artikel
|
| 5 |
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer
|
Schuler, Martin
|
|
2012
|
134 |
3 |
p. 1149-1159
|
artikel
|
| 6 |
A prospective study of breast lymphedema: frequency, symptoms, and quality of life
|
Degnim, Amy C.
|
|
2012
|
134 |
3 |
p. 915-922
|
artikel
|
| 7 |
Association of sleep duration and breast cancer OncotypeDX recurrence score
|
Thompson, Cheryl L.
|
|
2012
|
134 |
3 |
p. 1291-1295
|
artikel
|
| 8 |
Atypical ezrin localization as a marker of locally advanced breast cancer
|
Arslan, Alan A.
|
|
2012
|
134 |
3 |
p. 981-988
|
artikel
|
| 9 |
Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women
|
Banegas, Matthew P.
|
|
2012
|
134 |
3 |
p. 1297-1304
|
artikel
|
| 10 |
Cardiometabolic factors and breast cancer risk in U.S. black women
|
Bosco, Jaclyn L. F.
|
|
2012
|
134 |
3 |
p. 1247-1256
|
artikel
|
| 11 |
Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer
|
Kim, Haeyoung
|
|
2012
|
134 |
3 |
p. 1315-1326
|
artikel
|
| 12 |
Comments on adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease
|
Zhang, Chun
|
|
2012
|
134 |
3 |
p. 1347-1348
|
artikel
|
| 13 |
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients
|
Schwarzenbach, Heidi
|
|
2012
|
134 |
3 |
p. 933-941
|
artikel
|
| 14 |
Disparities in breast cancer mortality trends in a middle income country
|
Pedraza, Ana Maria
|
|
2012
|
134 |
3 |
p. 1199-1207
|
artikel
|
| 15 |
Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials
|
Jacquin, Jean-Philippe
|
|
2012
|
134 |
3 |
p. 903-913
|
artikel
|
| 16 |
Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management
|
Heidemann, Simone
|
|
2012
|
134 |
3 |
p. 1229-1239
|
artikel
|
| 17 |
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel–FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice
|
Pernas, Sonia
|
|
2012
|
134 |
3 |
p. 1161-1168
|
artikel
|
| 18 |
Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer
|
Wang, Neng
|
|
2012
|
134 |
3 |
p. 943-955
|
artikel
|
| 19 |
Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors
|
Chang, Jinjia
|
|
2012
|
134 |
3 |
p. 969-980
|
artikel
|
| 20 |
Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy
|
Moon, Hyeong-Gon
|
|
2012
|
134 |
3 |
p. 1133-1140
|
artikel
|
| 21 |
Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
|
Yang, Yi-ling
|
|
2012
|
134 |
3 |
p. 1095-1102
|
artikel
|
| 22 |
Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumours
|
Walker, Logan C.
|
|
2012
|
134 |
3 |
p. 1005-1011
|
artikel
|
| 23 |
Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway
|
Chen, Li-Ching
|
|
2012
|
134 |
3 |
p. 989-1004
|
artikel
|
| 24 |
Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study
|
Hoesel, Anneke Q. van
|
|
2012
|
134 |
3 |
p. 1103-1114
|
artikel
|
| 25 |
Impact of real-time virtual sonography, a coordinated sonography and MRI system that uses an image fusion technique, on the sonographic evaluation of MRI-detected lesions of the breast in second-look sonography
|
Nakano, Shogo
|
|
2012
|
134 |
3 |
p. 1179-1188
|
artikel
|
| 26 |
Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990–2008
|
Schlichting, Jennifer A.
|
|
2012
|
134 |
3 |
p. 1257-1268
|
artikel
|
| 27 |
Letter in response: the value of mammography screening
|
Burton, Robert C.
|
|
2012
|
134 |
3 |
p. 1345-1346
|
artikel
|
| 28 |
Lipid profiles within the SABRE trial of anastrozole with and without risedronate
|
Van Poznak, Catherine
|
|
2012
|
134 |
3 |
p. 1141-1147
|
artikel
|
| 29 |
Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution
|
Botteri, E.
|
|
2012
|
134 |
3 |
p. 1221-1228
|
artikel
|
| 30 |
Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation
|
Sikora, Matthew J.
|
|
2012
|
134 |
3 |
p. 1027-1039
|
artikel
|
| 31 |
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer
|
Cheng, Chun-Wen
|
|
2012
|
134 |
3 |
p. 1081-1093
|
artikel
|
| 32 |
Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres
|
Yanowsky, Kira
|
|
2012
|
134 |
3 |
p. 1337-1343
|
artikel
|
| 33 |
Nomogram for predicting positive resection margins after breast-conserving surgery
|
Shin, Hee-Chul
|
|
2012
|
134 |
3 |
p. 1115-1123
|
artikel
|
| 34 |
Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy
|
Mahéo, Karine
|
|
2012
|
134 |
3 |
p. 1013-1025
|
artikel
|
| 35 |
Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration
|
Kim, Su-Hyeong
|
|
2012
|
134 |
3 |
p. 1067-1079
|
artikel
|
| 36 |
Patterns of bone density evaluation in a community population treated with aromatase inhibitors
|
Ligibel, Jennifer A.
|
|
2012
|
134 |
3 |
p. 1305-1313
|
artikel
|
| 37 |
Protective effect of longstanding lactation and reproductive factors: a case–control study in North Tanzania
|
Hou, Ningqi
|
|
2011
|
134 |
3 |
p. 1349-1351
|
artikel
|
| 38 |
Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry
|
Work, Meghan E.
|
|
2012
|
134 |
3 |
p. 1209-1220
|
artikel
|
| 39 |
Selenium intake and breast cancer mortality in a cohort of Swedish women
|
Harris, Holly R.
|
|
2012
|
134 |
3 |
p. 1269-1277
|
artikel
|
| 40 |
Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem-like enriched mammosphere cells
|
Pollock, C. B.
|
|
2012
|
134 |
3 |
p. 1041-1055
|
artikel
|
| 41 |
Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer
|
Li, Haiyan
|
|
2012
|
134 |
3 |
p. 1057-1066
|
artikel
|
| 42 |
The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study
|
Campana, Luca G.
|
|
2012
|
134 |
3 |
p. 1169-1178
|
artikel
|
| 43 |
The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors
|
Bock, Meredith
|
|
2012
|
134 |
3 |
p. 1327-1335
|
artikel
|
| 44 |
Tumour characteristics among women with very low-risk breast cancer
|
Narod, S. A.
|
|
2012
|
134 |
3 |
p. 1241-1246
|
artikel
|
| 45 |
Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
|
Schneider, Jeffrey G.
|
|
2012
|
134 |
3 |
p. 1125-1132
|
artikel
|
Tijdschrift beschrijving